Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging

Heart
Antonio EspositoA Del Maschio

Abstract

Areas of intramyocardial late enhancement (LE) at delayed enhanced magnetic resonance imaging (DE-MRI) and reduction of myocardial phosphocreatine (PCr)/ATP-ratio at phosphorus magnetic resonance spectroscopy ((31)P-MRS) are both reported in hypertrophic cardiomyopathy (HCM) and indicate areas of increased interstitial myocardial space with fibrosis and impairment of myocardial energy metabolism, respectively. We sought to ascertain whether in HCM patients the abnormal features of left ventricular (LV) interstitial space revealed by DE-MRI correlated with impaired LV energy metabolism shown at (31)P-MRS. 19 patients with HCM proved by histological analysis of multiple endomyocardial biopsies and with normal coronary arteries, underwent cardiac MRI including DE-MRI and (31)P-MRS. DE-MRI for detection and quantification of late enhancement (LE) and (31)P-MRS to assess the myocardial PCr/ATP-ratio were performed by means of a 1.5-T magnet. 19 healthy subjects, matched for gender and age were studied by (31)P-MRS as control group. LE areas in the LV wall were found in 17 out of 19 patients with an extension ranging from 0.8% to 19.5% of the LV-mass (mean value 7.6% (SD 5.6%). The PCr/ATP-ratio was lower in HCM patients than in cont...Continue Reading

Citations

Sep 3, 2010·The Journal of Clinical Investigation·Polakit TeekakirikulJonathan G Seidman
May 20, 2014·Cardiovascular Research·E Rosalie Witjas-PaalberendsJolanda van der Velden
Oct 24, 2014·Radiology·Jan Bogaert, Iacopo Olivotto
Dec 23, 2016·Nature Reviews. Cardiology·David A BrownMihai Gheorghiade
Dec 16, 2016·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Joy S ShomeAmedeo Chiribiri
Jun 19, 2010·Journal of Cardiovascular Translational Research·Valentin FusterMarc A Miller
Jan 14, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Stefan A J TimmerAlbert C van Rossum
Feb 9, 2010·Expert Review of Cardiovascular Therapy·Roger Beadle, Michael Frenneaux
Apr 30, 2019·Medicine and Science in Sports and Exercise·Vincent L AengevaerenThijs M H Eijsvogels
Sep 28, 2010·The International Journal of Cardiovascular Imaging·Elif ElmasTheano Papavassiliu
Oct 9, 2019·Current Pharmaceutical Design·Hao JiangJunbo Ge
Jul 1, 2020·Journal of Cardiovascular Translational Research·Yuichi J ShimadaMichael A Fifer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.